WAZ Stock Overview Provides analytical workflow solutions in Asia, the Americas, and Europe. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Waters Corporation Competitors Price History & Performance
Summary of share price highs, lows and changes for Waters Historical stock prices Current Share Price US$397.20 52 Week High US$397.20 52 Week Low US$258.20 Beta 1.01 1 Month Change 12.30% 3 Month Change 35.79% 1 Year Change 33.29% 3 Year Change 37.92% 5 Year Change 102.65% Change since IPO 1,451.56%
Recent News & Updates
Investor sentiment improves as stock rises 19% Nov 08
Third quarter 2024 earnings released: EPS: US$2.72 (vs US$2.28 in 3Q 2023) Nov 01 Waters Corporation Raises Earnings Guidance for the Full Year of Fiscal Year Ending December 31, 2024
Now 21% undervalued Oct 18
Waters Corporation Announces New Bioseparations Tools Accelerate and Improve Development of Rna-Based Vaccines and Therapies Using LC-MS Analysis Oct 14
Waters Corporation Introduces TA Instruments Discovery Core Rheometer Oct 08 See more updates
Investor sentiment improves as stock rises 19% Nov 08
Third quarter 2024 earnings released: EPS: US$2.72 (vs US$2.28 in 3Q 2023) Nov 01 Waters Corporation Raises Earnings Guidance for the Full Year of Fiscal Year Ending December 31, 2024
Now 21% undervalued Oct 18
Waters Corporation Announces New Bioseparations Tools Accelerate and Improve Development of Rna-Based Vaccines and Therapies Using LC-MS Analysis Oct 14
Waters Corporation Introduces TA Instruments Discovery Core Rheometer Oct 08
Now 21% undervalued after recent price drop Aug 22
Now 23% undervalued Aug 05
Second quarter 2024 earnings released: EPS: US$2.41 (vs US$2.56 in 2Q 2023) Aug 01 Waters Corporation to Report Q2, 2024 Results on Jul 31, 2024
Waters Corporation New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs Jul 23
Now 24% undervalued after recent price drop Jul 01
Now 21% undervalued after recent price drop Jun 22
Waters Corporation Provides Earnings Guidance for the Second Quarter and Full Year of 2024 May 08
First quarter 2024 earnings released: EPS: US$1.73 (vs US$2.39 in 1Q 2023) May 07
Waters Corporation Accelerates the Development of Gene-Based Therapeutics with New GTxResolve Premier SEC Columns Apr 23
Waters Corporation, Annual General Meeting, May 23, 2024 Mar 30
Full year 2023 earnings released: EPS: US$10.87 (vs US$11.80 in FY 2022) Feb 29
Full year 2023 earnings released: EPS: US$10.87 (vs US$11.80 in FY 2022) Feb 07
Waters Corporation Provides Earnings Guidance for the First Quarter and Full-Year 2024 Feb 06
Third quarter 2023 earnings released: EPS: US$2.28 (vs US$2.61 in 3Q 2022) Nov 08
Now 21% undervalued after recent price drop Nov 07
Waters Corporation Announces Resignation of Jonathan Pratt as Senior Vice President of the Waters Division Oct 25
Waters Corporation Launched OligoWorks SPE Workflow and Kits Oct 20
Now 21% undervalued Oct 13
Waters Corporation Introduces DynaPro™? ZetaStar™? Instrument from its Wyatt Technology™? Portfolio for Nanoparticle Analysis Sep 21
Waters Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2023 Aug 04
Second quarter 2023 earnings released: EPS: US$2.56 (vs US$2.74 in 2Q 2022) Aug 03
Waters Corporation Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications Aug 02 Waters Corporation Boosts Resolution and Triples Scan Speed of Select Series MRT for Metabolomics and MS Imaging
Waters Corporation Provides Earnings Guidance for the Second Quarter of 2023 and Fiscal Year 2023 May 10
First quarter 2023 earnings released: EPS: US$2.39 (vs US$2.64 in 1Q 2022) May 09
Independent Director recently bought €940k worth of stock Mar 02
Waters Corporation Provides Earnings Guidance for the First Quarter of 2023 and Fiscal Year 2023 Feb 16
Full year 2022 earnings released: EPS: US$11.80 (vs US$11.25 in FY 2021) Feb 16
Waters Corporation Announces Waters_Connect™ System Monitoring Jan 26
Waters Corporation Announces Executive Changes Dec 15
Independent Director recently sold €344k worth of stock Dec 03
High number of new directors Dec 02
Waters Corporation Appoints Dan Brennan and Mark Vergnano to Board of Directors Nov 24
Waters Introduces New PFAS Quantitation Workflow Enabled by Enhancements to Waters_Connect Informatics Platform Nov 23
Third quarter 2022 earnings released: EPS: US$2.61 (vs US$2.63 in 3Q 2021) Nov 02
Waters Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022 Nov 02
Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot Oct 12
Waters Extends Capabilities of Flagship Ta Instruments Rheometer for Efficient and Repeatable Powder Analysis Sep 30
Second quarter 2022 earnings released: EPS: US$2.74 (vs US$2.71 in 2Q 2021) Aug 03 Waters Corporation Provides Earnings Guidance for the Third Quarter Ending October 1, 2022 and Full Year Ending December 31, 2022
Waters Corporation to Report Q2, 2022 Results on Aug 02, 2022 Jul 13
Waters Corporation(NYSE:WAT) dropped from Russell 1000 Value-Defensive Index Jun 26
Waters Corporation Introduces High Resolution Mass Spectrometry Products and Software to Accelerate Drug Development Jun 07
Waters Corporation Provides Earnings Guidance for the Quarter Ending July 2, 2022 and Full Year Ending December 31, 2022 May 05
First quarter 2022 earnings released: EPS: US$2.64 (vs US$2.38 in 1Q 2021) May 04
Waters Corporation, Annual General Meeting, May 24, 2022 Apr 15
Waters Corporation Announces Resignation of John Ballbach from the Board of Directors Apr 03
Waters Introduces Xevo TQ Absolute Apr 01
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 04
Waters Corporation Provides Earnings Guidance for the First Quarter Ending April 2, 2022 and Year Ending December 31, 2022 Feb 02
Third quarter 2021 earnings released: EPS US$2.63 (vs US$2.05 in 3Q 2020) Nov 03
High number of new directors Nov 02
High number of new directors Oct 31
Independent Director Michael Berendt has left the company Oct 12
Waters Corporation Introduces the Waters™ BioAccord™ System Sep 15
Lead Independent Director recently sold €2.8m worth of stock Aug 08
Waters Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2021 Aug 05
Second quarter 2021 earnings released: EPS US$2.71 (vs US$1.99 in 2Q 2020) Aug 04
Waters Corporation Introduces TRIOS AutoPilot Software Jun 30
Waters Corp. Introduces the Waters Arc Premier System Jun 24
Waters Corporation Introduces the Sars-Cov-2 Lc-Ms Kit (Ruo) to Advance Clinical Research of Infectious Diseases May 26
Independent Director recently sold €302k worth of stock May 26
Independent Director has left the company May 19
First quarter 2021 earnings released: EPS US$2.38 (vs US$0.86 in 1Q 2020) May 06
Waters Corporation Provides Earnings Guidance for the Three Months Ended July 3, 2021 and for the Full Year Ended December 31, 2021 May 06
Waters Corporation Introduces A New Peptide Multi-Attribute Method Workflow for the Waters BioAccord LC-MS System Mar 19
Waters Corporation Improves Ease and Reliability of Small Molecule Analysis with ACQUITY RDa Detector Mar 11
Full year 2020 earnings released: EPS US$8.40 (vs US$8.76 in FY 2019) Feb 26
Revenue beats expectations Feb 26
Waters and TetraScience Partner to Deliver New Levels of Data Access and Insights with Empower Data Science Link Feb 25
New 90-day high: €242 Feb 04
Full year 2020 earnings released: EPS US$8.40 (vs US$8.76 in FY 2019) Feb 04
Revenue beats expectations Feb 04
Waters Corporation Introduces the OttoTM SPEcialist Positive Pressure Manifold Jan 29
Waters Corporation's APGC-MS/MS System Accepted for Advanced Dioxin and Furan Analysis Following USEPA Approval of SGS AXYS Method 16130 Jan 12
New 90-day high: €206 Jan 07
New 90-day high: €198 Dec 12
Waters Corporation Appoints Pearl S. Huang to Board of Directors Dec 11 Waters Corporation Announces CFO Changes
Megadalton Solutions, Inc. Announces Expansion of Collaboration with Waters Corporation Nov 19
New 90-day high: €197 Nov 16
Waters Corporation Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact RADIAN ASAP System Nov 05
New 90-day high: €193 Oct 30 Shareholder Returns WAZ DE Life Sciences DE Market 7D 1.9% 3.4% 1.9% 1Y 33.3% 3.1% 15.1%
See full shareholder returns
Return vs Market: WAZ exceeded the German Market which returned 15.2% over the past year.
Price Volatility Is WAZ's price volatile compared to industry and market? WAZ volatility WAZ Average Weekly Movement 6.8% Life Sciences Industry Average Movement 7.6% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.2% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: WAZ's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: WAZ's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Show more Waters Corporation Fundamentals Summary How do Waters's earnings and revenue compare to its market cap? WAZ fundamental statistics Market cap €23.90b Earnings (TTM ) €600.66m Revenue (TTM ) €2.80b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) WAZ income statement (TTM ) Revenue US$2.91b Cost of Revenue US$1.17b Gross Profit US$1.74b Other Expenses US$1.11b Earnings US$622.64m
Last Reported Earnings
Sep 28, 2024
Next Earnings Date
Feb 12, 2025
Earnings per share (EPS) 10.49 Gross Margin 59.73% Net Profit Margin 21.43% Debt/Equity Ratio 115.6%
How did WAZ perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/31 04:03 End of Day Share Price 2025/01/31 00:00 Earnings 2024/09/28 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Waters Corporation is covered by 45 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Catherine Ramsey Schulte Baird Charles Butler Barclays Luke Sergott Barclays
Show 42 more analysts 
